Tilray | TRLY - Market Capitalization

Stock Price
7.28
Daily Change
-0.26 -3.45%
Monthly
-22.22%
Yearly
970.59%
Q2 Forecast
7.13

Tilray reported $5.65B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 5M 5M Sep/2025
Aurora Cannabis CAD 327.21M 142.93M Dec/2025
Avita Medical AUD 105.47M 35.32M Dec/2025
Canopy Growth CAD 656.46M 124.89M Dec/2025
Cronos Group USD 1.43B 475.59M May/2026
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Divis Laboratories Ltd INR 1.7T 186.62B Dec/2025
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
IQVIA Holdings USD 31.35B 2.72B May/2026
Knight Therapeutics CAD 600.53M 14.56M Dec/2025
Moderna USD 20.15B 8.53B Mar/2026
Organigram Holdings CAD 312.16M 66.64M Dec/2025
Revvity USD 11.4B 1.46B May/2026
Tectonic Therapeutic USD 390M 96M Dec/2025
Viatris USD 20.65B 4.92B May/2026
Xeris Pharmaceuticals USD 1.3B 12M Dec/2025
Zealand Pharma A/S 33.35B 448.34M Dec/2025